We are live on ! Find out more
MGCD

MGC Diagnostics Corporation
MGCD

Delisted

MGCD was delisted on the 28th of December, 2017.

Back to rankings

19 hedge funds and large institutions have $8.27M invested in MGC Diagnostics Corporation in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more funds holding

Funds holding: 17 → 19 (+2)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

1% less capital invested

Capital invested by funds: $8.39M → $8.27M (-$121K)

Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Creative Planning
Creative Planning
Kansas
+$296K
2
Renaissance Technologies
Renaissance Technologies
New York
+$65.9K
3
ASN
Advisory Services Network
Georgia
+$7.55K
4
Deutsche Bank
Deutsche Bank
Germany
+$6.81K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$3.82K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$411K
2
BlackRock
BlackRock
New York
-$37.2K
3
Bank of America
Bank of America
North Carolina
-$518
4
UBS Group
UBS Group
Switzerland
-$189
5
Morgan Stanley
Morgan Stanley
New York
-$173
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$2.3M +$65.9K +8,005 +3%
PA
2
Perceptive Advisors
New York
$2.14M -$411K -50,000 -17%
BlackRock
3
BlackRock
New York
$823K -$37.2K -4,524 -4%
FM
4
Fondren Management
Texas
$797K – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$682K – – –
PCM
6
Perritt Capital Management
Illinois
$574K – – –
BGIM
7
Brandywine Global Investment Management
Pennsylvania
$363K – – –
Creative Planning
8
Creative Planning
Kansas
$296K +$296K +36,039 New
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$138K – – –
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$83K – – –
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$22K +$3.82K +464 +21%
PCM
12
Prelude Capital Management
New York
$14K +$2.87K +349 +26%
ASN
13
Advisory Services Network
Georgia
$13K +$7.55K +918 +130%
JIR
14
James Investment Research
Ohio
$9K – – –
Deutsche Bank
15
Deutsche Bank
Germany
$9K +$6.81K +828 +258%
UBS Group
16
UBS Group
Switzerland
$6K -$189 -23 -3%
Bank of America
17
Bank of America
North Carolina
$1K -$518 -63 -39%
TRCT
18
Tower Research Capital (TRC)
New York
$1K +$823 +100 New
Morgan Stanley
19
Morgan Stanley
New York
– -$173 -21 -68%

MGCD Hedge Fund Activity: Q2 2017 in Review

19 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics Corporation (MGCD) for Q2 2017, worth a combined $8.27M — down 1.4% from $8.39M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new MGCD positions and 0 closed out — a net gain of 2 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was Creative Planning, opening a new position worth an estimated $296K. The largest seller was Perceptive Advisors, cutting an estimated $411K.

  • 19 institutional investors held MGC Diagnostics Corporation (MGCD) as of Q2 2017, up from 17 in Q1 2017.
  • Funds reported $8.27M of MGC Diagnostics Corporation stock for Q2 2017, down 1.4% quarter-over-quarter.
  • 2 funds opened new MGC Diagnostics Corporation positions in Q2 2017 and 0 closed out, a net change of +2 holders.
  • The largest MGC Diagnostics Corporation buyer in Q2 2017 was Creative Planning, an estimated $296K added.
  • The largest MGC Diagnostics Corporation seller in Q2 2017 was Perceptive Advisors, an estimated $411K sold.

Based on aggregated 13F filings for Q2 2017.